1-1 of 1
on behalf of the Israeli CLL Study Group
Close
Sort by
Journal Articles

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Clinical Trials & Observations
Yair Herishanu, Galia Rahav, Shai Levi, Andrei Braester, Gilad Itchaki, Osnat Bairey, Najib Dally, Lev Shvidel, Tomer Ziv-Baran, Aaron Polliack, Tamar Tadmor, Ohad Benjamini, on behalf of the Israeli CLL Study Group
Journal: Blood
Blood (2022) 139 (5): 678–685.
https://doi.org/10.1182/blood.2021014085
Published: 2022
Includes: Supplemental data